{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:56Z","timestamp":1787021096373,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The National Administration of Traditional Chinese Medicine's High-Level Traditional Chinese Medicine Key Discipline Construction Project - Ethnic Minority Pharmacy","award":["No. zyyzdxk-2023165"],"award-info":[{"award-number":["No. zyyzdxk-2023165"]}]},{"name":"Qingmiao Project Talent Cultivation Program of Guangxi International Zhuang Medicine Hospital","award":["No. 2022001"],"award-info":[{"award-number":["No. 2022001"]}]},{"name":"Guangxi Traditional Chinese Medicine Multidisciplinary Interdisciplinary Innovation Team Project","award":["No. GZKJ2309"],"award-info":[{"award-number":["No. GZKJ2309"]}]},{"name":"Guangxi International Zhuang Medicine Hospital High-Level Talent Team Construction Three-Year Action Plan Project","award":["No. GZCX20231203"],"award-info":[{"award-number":["No. GZCX20231203"]}]},{"name":"The Third Batch of 'Qi Huang Project' High-Level Talent Team Cultivation Project of Guangxi University of Chinese Medicine","award":["No. 202414"],"award-info":[{"award-number":["No. 202414"]}]},{"name":"2024 Open Subjects of Guangxi Zhuang Medicine Longlu Disease Key Research Laboratory","award":["No. 2024KFKT005"],"award-info":[{"award-number":["No. 2024KFKT005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In non-Hodgkin\u2019s lymphoma, diffuse large b-cell lymphoma (DLBCL) is one of the most prevalent and commonly diagnosed subtypes. There is a need to develop more effective drugs since the currently approved drugs still have limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      DLBCL cell lines were intervened with different concentrations of\n                      <jats:italic>Damnacanthus giganteus<\/jats:italic>\n                      extract (DGE). The malignant phenotype of DLBCL cells was detected by CCK-8, colony formation assay, AnnexinV-PI double staining assay, and Transwell. The effect of DGE on the in vivo growth of DLBCL cells was assessed by nude mice transplantation tumor assay and immunohistochemistry. Cellular mitochondrial function was assessed by measuring mitochondrial ROS levels, MMP, and ATP production, and glycolysis was assessed by determining glucose uptake and lactate production. The changes of epithelial-mesenchymal transition (EMT) markers were evaluated via Western blot.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Intervention with low-toxicity concentrations of DGE significantly inhibited proliferative capacity and clonogenic potential in DLBCL cells while concurrently enhancing apoptosis and cisplatin sensitivity. DGE treatment also suppressed migratory and invasive behaviors, accompanied by downregulation of mesenchymal markers N-cadherin and Vimentin. In vivo studies confirmed therapeutic efficacy, with DGE monotherapy showing marked tumor growth suppression and synergistic activity with cisplatin. Mechanistically, DGE exacerbated mitochondrial dysfunction and suppressed glycolysis. This mitochondrial impairment phenotype elicited by DGE treatment was recapitulated using the mitochondrial complex I inhibitor Rotenone, which similarly induced proliferation inhibition and EMT modulation. Furthermore, the ROS scavenger N-acetylcysteine partially rescued DGE-induced cellular alterations, including proliferation and EMT suppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\u200cOur study demonstrates for the first time that DGE effectively suppresses tumor proliferation and EMT during DLBCL progression. These antitumor effects appear to be mediated through modulation of mitochondrial function and glycolysis. These findings position DGE as a promising novel therapeutic candidate for DLBCL treatment, meriting immediate clinical translation and further evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00531-3","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T15:06:32Z","timestamp":1756134392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Damnacanthus giganteus extract block diffuse large b-cell lymphoma proliferation and EMT by regulating mitochondrial dysfunction and glycolysis"],"prefix":"10.1186","volume":"162","author":[{"given":"Peng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuangYun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiuMei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingTao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZuJie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuLing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiangCun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"10091","key":"531_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017;390(10091):298\u2013310.","journal-title":"Lancet"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","volume":"13","author":"Y Chu","year":"2023","unstructured":"Chu Y, Liu Y, Fang X, Jiang Y, Ding M, Ge X, et al. The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and Temporal trends. Front Oncol. 2023;13:1059914.","journal-title":"Front Oncol"},{"issue":"5","key":"531_CR3","doi-asserted-by":"publisher","first-page":"e7056","DOI":"10.1002\/cam4.7056","volume":"13","author":"J Huang","year":"2024","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, et al. Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries. Cancer Med. 2024;13(5):e7056.","journal-title":"Cancer Med"},{"issue":"3","key":"531_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"531_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-Cell lymphoma. N Engl J Med. 2021;384(9):842\u201358.","journal-title":"N Engl J Med"},{"issue":"1","key":"531_CR6","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"531_CR7","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","volume":"23","author":"P Feugier","year":"2005","unstructured":"Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferm\u00e9 C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the groupe d\u2019etude des lymphomes de l\u2019adulte. J Clin Oncol. 2005;23(18):4117\u201326.","journal-title":"J Clin Oncol"},{"key":"531_CR8","doi-asserted-by":"crossref","unstructured":"Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 20172018;130(16):1800\u20138.","DOI":"10.1182\/blood-2017-03-769620"},{"issue":"6","key":"531_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/cpr.12143","volume":"47","author":"L Ouyang","year":"2014","unstructured":"Ouyang L, Luo Y, Tian M, Zhang SY, Lu R, Wang JH, et al. Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif. 2014;47(6):506\u201315.","journal-title":"Cell Prolif"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","volume":"40\u201341","author":"NS Yarla","year":"2016","unstructured":"Yarla NS, Bishayee A, Sethi G, Reddanna P, Kalle AM, Dhananjaya BL, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol. 2016;40\u201341:48\u201381.","journal-title":"Semin Cancer Biol"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"109570","DOI":"10.1016\/j.biopha.2019.109570","volume":"121","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Q, Chen Y, Liang CL, Liu H, Qiu F, Dai Z. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother. 2020;121:109570.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"531_CR12","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cam4.2108","volume":"8","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958\u201375.","journal-title":"Cancer Med"},{"issue":"7","key":"531_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4155\/fmc-2019-0322","volume":"12","author":"W Tian","year":"2020","unstructured":"Tian W, Wang C, Li D, Hou H. Novel anthraquinone compounds as anticancer agents and their potential mechanism. Future Med Chem. 2020;12(7):627\u201344.","journal-title":"Future Med Chem"},{"key":"531_CR14","doi-asserted-by":"crossref","unstructured":"Zhao L, Zheng L. A review on bioactive anthraquinone and derivatives as the regulators for ROS. Molecules. 2023;28(24).","DOI":"10.3390\/molecules28248139"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"1368371","DOI":"10.1155\/2019\/1368371","volume":"2019","author":"S Long","year":"2019","unstructured":"Long S, Yuan C, Wang Y, Zhang J, Li G. Network Pharmacology analysis of Damnacanthus indicus c.f.gaertn in Gene-Phenotype. Evid Based Complement Alternat Med. 2019;2019:1368371.","journal-title":"Evid Based Complement Alternat Med"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"115971","DOI":"10.1016\/j.taap.2022.115971","volume":"441","author":"Y Lu","year":"2022","unstructured":"Lu Y, Zhang P, Chen H, Tong Q, Wang J, Li Q, et al. Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B. Toxicol Appl Pharmacol. 2022;441:115971.","journal-title":"Toxicol Appl Pharmacol"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.mam.2023.101205","volume":"93","author":"R Mattioli","year":"2023","unstructured":"Mattioli R, Ilari A, Colotti B, Mosca L, Fazi F, Colotti G. Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming. Mol Aspects Med. 2023;93:101205.","journal-title":"Mol Aspects Med"},{"issue":"3","key":"531_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28(3):265\u201380.","journal-title":"Cell Res"},{"issue":"1","key":"531_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"SF Wang","year":"2023","unstructured":"Wang SF, Tseng LM, Lee HC. Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci. 2023;30(1):61.","journal-title":"J Biomed Sci"},{"issue":"3215","key":"531_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269\u201370.","journal-title":"Science"},{"issue":"Pt 2","key":"531_CR21","doi-asserted-by":"publisher","first-page":"117271","DOI":"10.1016\/j.jep.2023.117271","volume":"319","author":"XZ Zhan","year":"2024","unstructured":"Zhan XZ, Wei TH, Yin YQ, Xu JQ, Yu H, Chen XL, et al. Determination and mechanism of Xiao-Ai Jie-Du Decoction against diffuse large B-cell lymphoma: in Silico and in vitro studies. J Ethnopharmacol. 2024;319(Pt 2):117271.","journal-title":"J Ethnopharmacol"},{"key":"531_CR22","doi-asserted-by":"crossref","unstructured":"Wei C, Hu M, Hu Q. Network pharmacology, molecular docking, and experimental validation of the mechanism of Jiedu Xiaoliu formula against diffuse large B-Cell lymphoma. Comb Chem High Throughput Screen. 2024.","DOI":"10.2174\/0113862073290877240604102022"},{"key":"531_CR23","doi-asserted-by":"crossref","unstructured":"Ni X, Yu S, Jiang X, Wu F, Zhou J, Mao D et al. Celastrus orbiculatus thunb. Extract targeting DJ-1 inhibits non-small cell lung cancer invasion and metastasis through mitochondrial-induced ROS accumulation. J Ethnopharmacol. 2024;318(Pt A):116944.","DOI":"10.1016\/j.jep.2023.116944"},{"key":"531_CR24","doi-asserted-by":"crossref","unstructured":"Chen JH, Lin TH, Chien YC, Chen CY, Lin CT, Kuo WW, Chang WC. Aqueous extracts of ocimum gratissimum sensitize hepatocellular carcinoma cells to cisplatin through BRCA1 Inhibition. Int J Mol Sci. 2024;25(15).","DOI":"10.3390\/ijms25158424"},{"key":"531_CR25","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez ASC, Valencia MG, Cervantes-Villagrana RD, Zapata AB, Cervantes-Villagrana AR. Cytotoxic and antitumor effects of the hydroalcoholic extract of Tagetes erecta in lung cancer cells. Molecules. 2023;28(20).","DOI":"10.3390\/molecules28207055"},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2017.05.002","volume":"47","author":"P Deng","year":"2017","unstructured":"Deng P, Haynes CM. Mitochondrial dysfunction in cancer: potential roles of ATF5 and the mitochondrial UPR. Semin Cancer Biol. 2017;47:43\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"531_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","volume":"74","author":"C Raggi","year":"2021","unstructured":"Raggi C, Taddei ML, Sacco E, Navari N, Correnti M, Piombanti B, et al. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. J Hepatol. 2021;74(6):1373\u201385.","journal-title":"J Hepatol"},{"issue":"9","key":"531_CR28","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1021\/acs.jmedchem.2c01844","volume":"66","author":"P He","year":"2023","unstructured":"He P, Feng J, Xia X, Sun Y, He J, Guan T, et al. Discovery of a potent and oral available complex I OXPHOS inhibitor that abrogates tumor growth and circumvents MEKi resistance. J Med Chem. 2023;66(9):6047\u201369.","journal-title":"J Med Chem"},{"key":"531_CR29","doi-asserted-by":"crossref","unstructured":"Lee HY, Nga HT, Tian J, Yi HS. Mitochondrial metabolic signatures in hepatocellular carcinoma. Cells. 2021;10(8).","DOI":"10.3390\/cells10081901"},{"issue":"7","key":"531_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","volume":"29","author":"L Sainero-Alcolado","year":"2022","unstructured":"Sainero-Alcolado L, Lia\u00f1o-Pons J, Ruiz-P\u00e9rez MV, Arsenian-Henriksson M. Targeting mitochondrial metabolism for precision medicine in cancer. Cell Death Differ. 2022;29(7):1304\u201317.","journal-title":"Cell Death Differ"},{"issue":"1","key":"531_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12967-023-04188-2","volume":"21","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang B, Tu C, Ping Y, Chen S, Wu T, et al. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of Alantolactone on oral squamous cell carcinoma cells. J Transl Med. 2023;21(1):328.","journal-title":"J Transl Med"},{"issue":"35","key":"531_CR32","doi-asserted-by":"publisher","first-page":"e2303535","DOI":"10.1002\/advs.202303535","volume":"10","author":"Q Hu","year":"2023","unstructured":"Hu Q, Xu J, Wang L, Yuan Y, Luo R, Gan M, et al. SUCLG2 regulates mitochondrial dysfunction through succinylation in lung adenocarcinoma. Adv Sci (Weinh). 2023;10(35):e2303535.","journal-title":"Adv Sci (Weinh)"},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"106019","DOI":"10.1016\/j.bioorg.2022.106019","volume":"127","author":"S Yao","year":"2022","unstructured":"Yao S, Yin J, Liu W, Li Y, Huang J, Qi C, et al. A novel Gboxin analog induces OXPHOS Inhibition and mitochondrial dysfunction-mediated apoptosis in diffuse large B-cell lymphoma. Bioorg Chem. 2022;127:106019.","journal-title":"Bioorg Chem"},{"issue":"17","key":"531_CR34","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1158\/1078-0432.CCR-21-0464","volume":"27","author":"T Liu","year":"2021","unstructured":"Liu T, Lam V, Thieme E, Sun D, Wang X, Xu F, et al. Pharmacologic targeting of Mcl-1 induces mitochondrial dysfunction and apoptosis in B-Cell lymphoma cells in a TP53- and BAX-Dependent manner. Clin Cancer Res. 2021;27(17):4910\u201322.","journal-title":"Clin Cancer Res"},{"key":"531_CR35","doi-asserted-by":"crossref","unstructured":"Feng Q, Hu K, Hu H, Lu Y, Zhang H, Wang G et al. Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells. Int Immunopharmacol. 2023;125(Pt A):111139.","DOI":"10.1016\/j.intimp.2023.111139"},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.exphem.2023.04.002","volume":"123","author":"P Liu","year":"2023","unstructured":"Liu P, Zhao M, Lin Y, Jiang X, Xia T, Li Y, et al. Platycodin D induces proliferation Inhibition and mitochondrial apoptosis in diffuse large B-cell lymphoma. Exp Hematol. 2023;123:46\u2013e551.","journal-title":"Exp Hematol"},{"issue":"18","key":"531_CR37","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1080\/15384101.2023.2247248","volume":"22","author":"W Wang","year":"2023","unstructured":"Wang W, Xu X, Zhao L, Ye K, Wang S, Lin C. 3,5-diCQA suppresses colorectal cancer cell growth through ros\/ampk\/mtor mediated mitochondrial dysfunction and ferroptosis. Cell Cycle. 2023;22(18):1951\u201368.","journal-title":"Cell Cycle"},{"issue":"1","key":"531_CR38","doi-asserted-by":"publisher","first-page":"114034","DOI":"10.1016\/j.yexcr.2024.114034","volume":"438","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang M, Zhang Z, Zhou S. Salidroside induces mitochondrial dysfunction and ferroptosis to inhibit melanoma progression through reactive oxygen species production. Exp Cell Res. 2024;438(1):114034.","journal-title":"Exp Cell Res"},{"issue":"1","key":"531_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):124.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"531_CR40","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: mechanism, roles in diseases and small molecule Pharmacological regulation. Theranostics. 2023;13(2):736\u201366.","journal-title":"Theranostics"},{"issue":"12","key":"531_CR41","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1111\/cas.15568","volume":"113","author":"M Wang","year":"2022","unstructured":"Wang M, Luan S, Fan X, Wang J, Huang J, Gao X, Han D. The emerging multifaceted role of PINK1 in cancer biology. Cancer Sci. 2022;113(12):4037\u201347.","journal-title":"Cancer Sci"},{"issue":"8","key":"531_CR42","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","volume":"78","author":"LP Poole","year":"2021","unstructured":"Poole LP, Macleod KF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci. 2021;78(8):3817\u201351.","journal-title":"Cell Mol Life Sci"},{"key":"531_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","volume":"66","author":"DP Panigrahi","year":"2020","unstructured":"Panigrahi DP, Praharaj PP, Bhol CS, Mahapatra KK, Patra S, Behera BP, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:45\u201358.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"531_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/0008-5472.CAN-22-2370","volume":"83","author":"Y Li","year":"2023","unstructured":"Li Y, Chen H, Xie X, Yang B, Wang X, Zhang J, et al. PINK1-Mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce Drug-Tolerant persister cancer cells. Cancer Res. 2023;83(3):398\u2013413.","journal-title":"Cancer Res"},{"issue":"3","key":"531_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41419-019-1470-z","volume":"10","author":"N Yao","year":"2019","unstructured":"Yao N, Wang C, Hu N, Li Y, Liu M, Lei Y, et al. Inhibition of PINK1\/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog. Cell Death Dis. 2019;10(3):232.","journal-title":"Cell Death Dis"},{"issue":"1","key":"531_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-023-02638-9","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res. 2023;42(1):65.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"531_CR47","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","volume":"18","author":"J Yao","year":"2022","unstructured":"Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, et al. CDK9 Inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy. 2022;18(8):1879\u201397.","journal-title":"Autophagy"},{"key":"531_CR48","doi-asserted-by":"publisher","first-page":"216616","DOI":"10.1016\/j.canlet.2024.216616","volume":"583","author":"WT Wang","year":"2024","unstructured":"Wang WT, Xing TY, Du KX, Hua W, Guo JR, Duan ZW, et al. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy. Cancer Lett. 2024;583:216616.","journal-title":"Cancer Lett"},{"issue":"1","key":"531_CR49","doi-asserted-by":"publisher","first-page":"2493556","DOI":"10.1080\/13510002.2025.2493556","volume":"30","author":"X Ma","year":"2025","unstructured":"Ma X, Li Z, Ma H, Jiang K, Chen B, Wang W, et al. Rotenone inhibited osteosarcoma metastasis by modulating ZO-2 expression and location via the ROS\/Ca(2+)\/AMPK pathway. Redox Rep. 2025;30(1):2493556.","journal-title":"Redox Rep"},{"key":"531_CR50","doi-asserted-by":"crossref","unstructured":"Xiang H, Sun J, Kong L, Wang Y, Qiu X, Zeng J et al. NDUFA8 promotes cell viability and inhibits ferroptosis and cisplatin sensitivity by stabilizing Fe-S clusters in cervical cancer. Naunyn Schmiedebergs Arch Pharmacol. 2025.","DOI":"10.1007\/s00210-025-04237-1"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00531-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00531-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:06:13Z","timestamp":1757433973000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00531-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00531-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of Guangxi University of Chinese Medicine (No. DW20240919-197).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"170"}}